Anika Therapeutics, Inc. - ANIK

SEC FilingsOur ANIK Tweets

About Gravity Analytica

Recent News

  • 11.12.2025 - End-of-Year Health Check: Planning for a Strong Start to 2026
  • 11.05.2025 - Anika Reports Third Quarter 2025 Financial Results
  • 10.23.2025 - Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
  • 10.06.2025 - Reimagining Achilles Tendon Repair with the Integrity Implant
  • 09.05.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 08.27.2025 - Why Choosing a Non-Xenograft Implant Matters
  • 07.30.2025 - Anika Reports Second Quarter 2025 Financial Results
  • 07.30.2025 - Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update

Recent Filings

  • 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 11.05.2025 - 8-K Current report
  • 11.05.2025 - EX-99.1 EX-99.1
  • 11.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 11.05.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 10.17.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 07.30.2025 - EX-99.1 EX-99.1
  • 07.30.2025 - 8-K Current report
  • 07.30.2025 - 8-K Current report
  • 07.30.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]